XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
25.49
+0.27 (1.07%)
At close: Dec 15, 2025, 4:00 PM EST
25.99
+0.50 (1.96%)
After-hours: Dec 15, 2025, 6:37 PM EST
XOMA Royalty Market Cap
XOMA Royalty has a market cap or net worth of $315.65 million as of December 15, 2025. Its market cap has decreased by -20.93% in one year.
Market Cap
315.65M
Enterprise Value
402.82M
1-Year Change
-20.93%
Ranking
Category
Stock Price
$25.49
Market Cap Chart
Since December 1, 1998, XOMA Royalty's market cap has increased from $151.40M to $315.65M, an increase of 108.48%. That is a compound annual growth rate of 2.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 312.30M | 0.87% |
| Dec 31, 2024 | 309.60M | 45.69% |
| Dec 29, 2023 | 212.50M | 0.85% |
| Dec 30, 2022 | 210.70M | -10.64% |
| Dec 31, 2021 | 235.80M | -51.52% |
| Dec 31, 2020 | 486.40M | 103.60% |
| Dec 31, 2019 | 238.90M | 125.16% |
| Dec 31, 2018 | 106.10M | -63.40% |
| Dec 29, 2017 | 289.90M | 1,036.86% |
| Dec 30, 2016 | 25.50M | -83.86% |
| Dec 31, 2015 | 158.00M | -59.01% |
| Dec 31, 2014 | 385.50M | -38.46% |
| Dec 31, 2013 | 626.40M | 220.08% |
| Dec 31, 2012 | 195.70M | 396.70% |
| Dec 30, 2011 | 39.40M | -64.76% |
| Dec 31, 2010 | 111.80M | -19.57% |
| Dec 31, 2009 | 139.00M | 69.31% |
| Dec 31, 2008 | 82.10M | -81.63% |
| Dec 31, 2007 | 447.00M | 100.18% |
| Dec 29, 2006 | 223.30M | 61.69% |
| Dec 30, 2005 | 138.10M | -37.68% |
| Dec 31, 2004 | 221.60M | -59.61% |
| Dec 31, 2003 | 548.60M | 84.40% |
| Dec 31, 2002 | 297.50M | -56.92% |
| Dec 31, 2001 | 690.50M | 7.32% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 951.07B |
| Johnson & Johnson | 516.00B |
| AbbVie | 401.99B |
| UnitedHealth Group | 308.98B |
| AstraZeneca | 282.48B |
| Novartis AG | 258.61B |
| Merck & Co. | 248.85B |
| Abbott Laboratories | 223.39B |